Dublin, March 28, 2017 -- Research and Markets has announced the addition of the "Sleep Management in the U.S.: Consumer Strategies" report to their offering.
Sleep Management in the U.S.: Consumer Strategies reveals that 82% of adults have trouble sleeping at least once a week, due to at least one of seven forms of sleep disturbance. This translates to 206 million troubled sleepers out of 249 million U.S. adults. But even frequent troubled sleep is commonplace, with 39% of adults (97 million) having trouble sleeping five or more times a week.
Sleep Management in the U.S.: Consumer Strategies provides industry participants with an organized, insight-driven roadmap to navigating consumers' sleep treatment and management strategies, helping to leverage market opportunity. The report focuses on how adults approach and treat sleep disturbances and sleep disorders, emphasizing consumer survey analysis, including trends over time. The report studies two distinct groups: troubled sleepers and adults who have specific sleep conditions/disorders. Demographic analysis of these groups is woven into report analysis.
Key Topics Covered:
Chapter 1: Executive Summary
Report Summary
Chapter 2: Introduction And Overview
Prevalence
Consequences
Major Sleep Disorders
Living With Sleep Disorders
Chapter 3: Troubled Sleepers And Sleep Disorders
Having Trouble Sleeping: Let Me Count The Ways
Sleep Disorders
Chapter 4: Sleep Treatment Management
Introduction
Responding To Pain And Sickness
Consumers' Preferred Approach To Managing Their Sleep Problems
Chapter 5: Drug Treatment Methods And Outcomes
Attitudes Toward Prescription And Non-Prescription Medicine
Use Of Drugs To Treat Sleep Problems And Disorders
Prescription Drugs Used For Used For Sleep
Non-Prescription Drugs Used For Sleep
Prescription Vs. Non-Prescription Drug Use, By Sleep Disorder
Chapter 6: Non-Drug Treatment Methods And Outcomes
Behavioral Change Methods
Vitamins & Supplements, And Natural Sleep Aids
Alternative Treatments
Health Professional Products And Retail Products
Appendix
Consumer Survey Methodology
Generations
Population Estimates
Relief Ratio
Sleep Disorder Classifications
Other Terms And Definitions
For more information about this report visit http://www.researchandmarkets.com/research/q7h2nl/sleep_management
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Healthcare Services, Pharmaceuticals


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Washington Post Publisher Will Lewis Steps Down After Layoffs
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



